RAFAEL HOLDINGS, INC. Due to Related Parties, Current
RAFAEL HOLDINGS, INC. (RFL) had Due to Related Parties, Current of $44.00 thousand as of 2022-10-31, per its 10-Q filed 2022-12-13.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2023-03-14
- 2022-10-31: Due to Related Parties, Current $44.00K.
- 2022-07-31: Due to Related Parties, Current $69.00K.
- 2022-04-30: Due to Related Parties, Current $69.00K.
- 2022-01-31: Due to Related Parties, Current $57.00K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2022-10-31 | $44.00K 10-Q · filed 2022-12-13 |
| 2022-07-31 | $69.00K 10-Q · filed 2023-03-14 |
| 2022-04-30 | $69.00K 10-Q · filed 2022-06-14 |
| 2022-01-31 | $57.00K 10-Q · filed 2022-03-17 |
| 2021-10-31 | $52.00K 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $136.00K 10-K · filed 2022-10-31 |
| 2021-04-30 | $60.00K 10-Q · filed 2021-06-14 |
| 2021-01-31 | $29.00K 10-Q · filed 2021-03-17 |
| 2020-10-31 | $30.00K 10-Q · filed 2020-12-15 |
| 2020-07-31 | $3.50M 10-K · filed 2020-10-29 |
| 2019-01-31 | $0.00 10-Q · filed 2019-03-12 |
| 2018-10-31 | $582.00K 10-Q · filed 2019-03-12 |
| 2018-07-31 | $276.00K 10-Q · filed 2019-03-12 |
| 2018-04-30 | -$621.00K 10-Q · filed 2018-06-11 |
| 2018-01-31 | $24.39M 10-Q · filed 2018-03-12 |
| 2017-07-31 | $23.69M 10-K · filed 2018-10-15 |
| 2017-04-30 | $33.15M 10-Q · filed 2018-06-11 |
| 2017-01-31 | $23.26M 10-Q · filed 2018-03-12 |
| 2016-07-31 | $15.14M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |